$DMTK $MSFT $AMGN ***BUY DMTK HERE*** So people are OBVIOUSLY just LYING on this board or believing BS about Cigna denying using Derm Tech's Cancer assay which Cigna did INDEED say they will cover this morning! Cigna states they follow NCCN guidelines which in turn means they will cover Derm Tech assays per NCCN. NCCN RECOMMENDATION! 1/12/2012: DMTK announced today that non-invasive genomic patch testing for melanoma, like DermTechs Pigmented Lesion Assay (PLA), has received a recommendation from the National Comprehensive Cancer Network® (NCCN). Jonah Lupton DID NOT SAY CIGNA WILL NOT COVER BUT ACTUALLY WILL COVER! BUY NOW IF YOU CAN! The cancer assay from Derm Tech is 97% sensitive which is will save Cigna and all healthcare providers millions if not billions over a few years! investors.dermtech.com/news... twitter.com/jonahlupton seekingalpha.com/news/36851... DMTK will outperform MSFT, AMGN and $NVAX from here. Their cost savings and growth will be unreal!
1
1
1 Like